Sulfonylureas Risks, Brain Aging in COVID, and Painkiller Shortages in Canada

In this episode, Dr. Chi-Ming Chow delves into the cardiovascular risks associated with sulfonylureas in Type 2 Diabetes, presenting recent study findings that compare these drugs with DPP4 inhibitors and their clinical implications. An editorial perspective offers insights into the affordability of treatments, choices, and study methodology. Dr. Chow updates listeners on the resident doctors' strike in England and explores research on accelerated brain aging during the COVID-19 pandemic. He questions the necessity of eating three meals a day and shares tips for enhancing daily walks. The episode also addresses a nationwide shortage of prescription painkillers in Canada, concluding with closing remarks.